This is a StreetInsider.com Premium Only Page

(PTPI) – StreetInsider.com Reports

Apr 23, 2024 09:19 AM Petros Pharmaceuticals (PTPI) Expands Online Distribution for Prescription STENDRA

Apr 16, 2024 09:18 AM Petros Pharma (PTPI) Receives Positive Response from FDA Following Recent Demonstration of Technology Component in Pursuit of OTC Status for STENDRA

Apr 2, 2024 09:18 AM Petros Pharmaceuticals, Inc (PTPI) Reports Positive Results in an Initial Cohort Two-Arm Self-Selection Study for STENDRA

Mar 19, 2024 09:02 AM Petros Pharmaceuticals (PTPI) Successfully Launches AI Tool

Feb 14, 2024 09:32 AM Petros Pharmaceuticals (PTPI) Enters AI Licensing Agreement with a Software Provider

Jan 24, 2024 09:21 AM Petros Pharmaceuticals (PTPI) Announces Two Upcoming FDA Meetings to Review Progress and Path Forward for STENDRA

Jan 17, 2024 09:03 AM Petros Pharmaceuticals, Inc (PTPI) Reports Positive Results from Initial Cohort of Phase 2 Study for STENDRA

Dec 12, 2023 01:01 PM Petros Pharmaceuticals (PTPI) Completes Study in Effort to Switch STENDRA to OTC Status

Dec 12, 2023 09:18 AM Petros Pharmaceuticals (PTPI) Partners with Crestor’s (rosuvastatin) OTC Switch Technology Provider

Dec 8, 2023 07:39 AM Maxim Group Starts Petros Pharmaceuticals Inc. (PTPI) at Buy

Dec 5, 2023 09:18 AM Petros Pharmaceuticals, Inc (PTPI) announces partnership with Idea Evolver

Oct 19, 2023 09:02 AM Petros Pharmaceuticals (PTPI) Initiates Self-Selection (Phase 2-Equivalent) Study for STENDRA

Oct 4, 2023 09:04 AM Petros Pharmaceuticals (PTPI) Announces Positive Outcomes in Label Comprehension Study for Potential OTC STENDRA Label

Sep 18, 2023 03:02 AM Petros Pharmaceuticals, Inc (PTPI) Announces 184.83M Share Offering by Selling Stockholders

Sep 11, 2023 09:02 AM Petros Pharmaceuticals (PTPI) Issues Letter to Shareholders

Aug 11, 2023 04:35 PM Petros Pharmaceuticals, Inc (PTPI) Announces 422.5K Share Offering by Selling Stockholders

Jul 13, 2023 04:32 PM Petros Pharmaceuticals (PTPI) Announces $15M Private Placement

May 30, 2023 08:02 AM Oblong (OBLG) Appoints Two New Directors to its Board

Apr 14, 2023 11:46 AM Petros Pharmaceuticals, Inc (PTPI) Extends Gian, Now Up 650%

Apr 14, 2023 10:42 AM Petros Pharmaceuticals, Inc (PTPI) Climbs 200%

Nov 30, 2022 12:46 PM Petros Pharmaceuticals, Inc (PTPI) Announces Reverse Stock Split

Oct 25, 2022 09:03 AM Petros Pharmaceuticals (PTPI) Announces FDA Label Expansion for STENDRA to Include Efficacy Data Regarding Use in Men Who Have Undergone Radical Prostatectomy

Jul 28, 2022 11:01 AM Petros Pharmaceuticals, Inc (PTPI) Resumes Trading

Jul 28, 2022 10:28 AM Petros Pharmaceuticals (PTPI) says press release on purported acquisition of the company was fraudulent

Jul 28, 2022 09:45 AM Petros Pharmaceuticals, Inc (PTPI) Halted, News Pending

Jul 28, 2022 09:25 AM (Ignore, company said this press release was fake) Petros Pharmaceuticals (PTPI) to be Acquired by Henry Crown and Company for $3.25 per share

May 3, 2022 09:24 AM Petros Pharmaceuticals, Inc (PTPI) to Pursue 505(B)(2) Pathway for H-100

Apr 26, 2022 09:18 AM Petros Pharmaceuticals (PTPI) Engages Massachusetts General Hospital in a Sponsored Research Agreement for Tissue-Specific Oxygenation Sensor Technology

Apr 19, 2022 09:15 AM Petros Pharmaceuticals (PTPI) Announces Positive Results of OTC Label Comprehension Study for Erectile Dysfunction Drug STENDRA

Jan 24, 2022 09:16 AM Petros Pharmaceuticals, Inc (PTPI) Partners with Contract Manufacturer to Bring Production of Erectile Dysfunction Drug STENDRAO to the US

Jan 3, 2022 09:06 AM Petros Pharmaceuticals, Inc (PTPI) Reports 145K Share Insider Buy

Jan 3, 2022 07:40 AM Insignia Systems (ISIG) Tops Fintel's Short Squeeze Leaderboard

Dec 27, 2021 06:46 AM Biofrontera (BFRI) Tops Short Squeeze Leaderboard at Fintel

Dec 22, 2021 09:10 AM Petros Pharmaceuticals, Inc (PTPI) Announces $7.5 Million Offering of of Common Stock, Warrants

Dec 21, 2021 10:04 AM Petros Pharmaceuticals, Inc (PTPI) Halted on LUDP

Dec 13, 2021 04:05 PM Petros Pharmaceuticals, Inc (PTPI) Announces 3.83M Share Offering by Selling Stockholders

Dec 10, 2021 10:27 AM Petros Pharmaceuticals, Inc (PTPI) Gaining 17% on Heavy Volume

Dec 8, 2021 09:16 AM Petros Pharmaceuticals, Inc (PTPI) Announces Positive Over-the-Counter Label Comprehension Study Results for Erectile Dysfunction Drug STENDRA

Nov 30, 2021 09:07 AM Petros Pharmaceuticals, Inc (PTPI) Announces 3.33M Share Offering at $3/sh

Nov 12, 2021 08:02 PM Petros Pharmaceuticals, Inc (PTPI) Files For Up to 3.45M Share Offering by Selling Stockholders

Nov 8, 2021 09:16 AM Petros Pharmaceuticals, Inc (PTPI) Expands Program for Non-Invasive Treatment Formulation for Peyronie's Disease

Nov 3, 2021 09:17 AM Petros Pharmaceuticals, Inc (PTPI) Reports 476% YoY Growth in STENDRA Tablet Sales

Oct 14, 2021 09:01 AM Petros Pharmaceuticals, Inc (PTPI) Announces Direct 3.32M Share Offering at $1.715/sh

Jul 27, 2021 09:27 AM Petros Pharmaceuticals, Inc (PTPI) Granted FDA Meeting to Discuss Label Expansion of STENDRA®